On Nov 18, 2021 Treadwell Therapeutics closed a Series B round and raised $91,000,000 from 3W Fund Management, Adrian Cheng, Alpha Win Capital, Fortune Ocean Growth Fund, Prosperous Alliance Investments, Sino Biopharmaceutical, TIO Bioventures, featuring lead investors 3W Fund Management, Sino Biopharmaceutical.

About the company: Treadwell Therapeutics is located at United States, North America.

Company website: http://www.treadwelltx.com

Leave a Reply

Your email address will not be published. Required fields are marked *